|
|
Volumn 3, Issue 8, 2013, Pages
|
|
BRAF and MEK inhibitors approved for melanoma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DABRAFENIB;
DACARBAZINE;
IPILIMUMAB;
MEKINIST;
PACLITAXEL;
TAFINLAR;
TRAMETINIB;
UNCLASSIFIED DRUG;
VEMURAFENIB;
DIAGNOSTIC TEST;
GENE MUTATION;
HUMAN;
MELANOMA;
MELANOMA SKIN CANCER;
MULTICENTER STUDY (TOPIC);
NOTE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PHOTOSENSITIVITY;
PHYSICIAN;
PROGRESSION FREE SURVIVAL;
TUMOR GROWTH;
|
|
EID: 84881541107
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2013-092 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|